|

Dapagliflozin Clinical Trials

11 actively recruiting trials across 4 locations

▲ +1 trial since June 2026

Also known as: FORXIGA, Farxiga, Forxiga, farxiga

Pipeline

Phase 1: 1Phase 3: 5Phase 4: 1Phase 1/2: 1Phase 2/3: 2

Top Sponsors

  • AstraZeneca2
  • Washington University School of Medicine1
  • University of Sao Paulo1
  • The University of Texas Health Science Center at San Antonio1
  • The George Institute1

Indications

Other7 trials

"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
Phase 2/3
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Phase 3
Dapagliflozin in Depression
Phase 1/2
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
Phase 4
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
Phase 3
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Phase 2/3
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Phase 3

Birmingham, Alabama1 trial

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site

Phase 3

Huntsville, Alabama1 trial

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site

Phase 3

St Louis, Missouri1 trial

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine/St. Louis Children's Hospital

Phase 1

San Antonio, Texas1 trial

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.